BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 24083740)

  • 21. Predictive and prognostic value of LPS-stimulated cytokine secretion in metastatic non-small cell lung cancer.
    Vlachostergios PJ; Gioulbasanis I; Ghosh S; Tsatsanis C; Papatsibas G; Xyrafas A; Hatzidaki E; Vasiliou C; Kamposioras K; Agelaki S; Margioris AN; Nasi D; Georgoulias V; Papandreou CN
    Clin Transl Oncol; 2013 Nov; 15(11):903-9. PubMed ID: 23463594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum semicarbazide-sensitive amine oxidase (SSAO) activity correlates with VEGF in non-small-cell lung cancer patients.
    Garpenstrand H; Bergqvist M; Brattström D; Larsson A; Oreland L; Hesselius P; Wagenius G
    Med Oncol; 2004; 21(3):241-50. PubMed ID: 15456951
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating interleukin-6 level is a prognostic marker for survival in advanced nonsmall cell lung cancer patients treated with chemotherapy.
    Chang CH; Hsiao CF; Yeh YM; Chang GC; Tsai YH; Chen YM; Huang MS; Chen HL; Li YJ; Yang PC; Chen CJ; Hsiung CA; Su WC
    Int J Cancer; 2013 May; 132(9):1977-85. PubMed ID: 23034889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Limited Clinical Significance of Dimeric Form of Pyruvate Kinase as a Diagnostic and Prognostic Biomarker in Non-small Cell Lung Cancer.
    Rzechonek A; Kaminska A; Mamczur P; Drapiewski A; Budzynski W
    Adv Exp Med Biol; 2017; 955():51-57. PubMed ID: 27683215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum levels of apoptosis biomarkers, survivin and TNF-alpha in nonsmall cell lung cancer.
    Derin D; Soydinç HO; Guney N; Tas F; Camlica H; Duranyildiz D; Yasasever V; Topuz E
    Lung Cancer; 2008 Feb; 59(2):240-5. PubMed ID: 17875341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum levels of vascular endothelial growth factor dependent on the stage progression of lung cancer.
    Matsuyama W; Hashiguchi T; Mizoguchi A; Iwami F; Kawabata M; Arimura K; Osame M
    Chest; 2000 Oct; 118(4):948-51. PubMed ID: 11035661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of preoperative serum CRP with PD-L1 expression in 508 patients with non-small cell lung cancer: A comprehensive analysis of systemic inflammatory markers.
    Akamine T; Takada K; Toyokawa G; Kinoshita F; Matsubara T; Kozuma Y; Haratake N; Takamori S; Hirai F; Tagawa T; Okamoto T; Yoneshima Y; Okamoto I; Shimokawa M; Oda Y; Nakanishi Y; Maehara Y
    Surg Oncol; 2018 Mar; 27(1):88-94. PubMed ID: 29549910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of interferon-gamma, interleukin-6, and tumor necrosis factor-alpha in the radiation response of patients diagnosed with locally advanced non-small-cell lung cancer and glioblastoma multiforme.
    Deniz ÇD; Gürbilek M; Koç M
    Turk J Med Sci; 2018 Feb; 48(1):117-123. PubMed ID: 29479968
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictive value of serum VEGF levels for elderly patients or for patients with poor performance status receiving anti-PD-1 antibody therapy for advanced non-small-cell lung cancer.
    Shibaki R; Murakami S; Shinno Y; Matsumoto Y; Yoshida T; Goto Y; Kanda S; Horinouchi H; Fujiwara Y; Yamamoto N; Yamamoto N; Ohe Y
    Cancer Immunol Immunother; 2020 Jul; 69(7):1229-1236. PubMed ID: 32152703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum vascular endothelial growth factor (VEGF) and bcl-2 levels in advanced stage non-small cell lung cancer.
    Tas F; Duranyildiz D; Oguz H; Camlica H; Yasasever V; Topuz E
    Cancer Invest; 2006 Oct; 24(6):576-80. PubMed ID: 16982461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The serum-based VeriStrat® test is associated with proinflammatory reactants and clinical outcome in non-small cell lung cancer patients.
    Fidler MJ; Fhied CL; Roder J; Basu S; Sayidine S; Fughhi I; Pool M; Batus M; Bonomi P; Borgia JA
    BMC Cancer; 2018 Mar; 18(1):310. PubMed ID: 29558888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The relationship between serum VEGF concentration and prognosis of lung cancer.
    Park SH; Lee SS
    Korean J Intern Med; 2003 Dec; 18(4):207-11. PubMed ID: 14717227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum pleiotrophin could be an early indicator for diagnosis and prognosis of non-small cell lung cancer.
    Du ZY; Shi MH; Ji CH; Yu Y
    Asian Pac J Cancer Prev; 2015; 16(4):1421-5. PubMed ID: 25743809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum IL-33 as a diagnostic and prognostic marker in non- small cell lung cancer.
    Hu LA; Fu Y; Zhang DN; Zhang J
    Asian Pac J Cancer Prev; 2013; 14(4):2563-6. PubMed ID: 23725175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum inflammatory cytokines IL-1beta, IL-6, TNF-alpha and VEGF have influence on the development of diabetic retinopathy.
    Koleva-Georgieva DN; Sivkova NP; Terzieva D
    Folia Med (Plovdiv); 2011; 53(2):44-50. PubMed ID: 21797106
    [TBL] [Abstract][Full Text] [Related]  

  • 36. VEGF, TNF-alpha and 8-isoprostane levels in exhaled breath condensate and serum of patients with lung cancer.
    Dalaveris E; Kerenidi T; Katsabeki-Katsafli A; Kiropoulos T; Tanou K; Gourgoulianis KI; Kostikas K
    Lung Cancer; 2009 May; 64(2):219-25. PubMed ID: 18845357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The value of serum Bcl-2 levels in advanced lung cancer patients.
    Tas F; Duranyildiz D; Oguz H; Camlica H; Oral EN; Yasasever V; Topuz E
    Med Oncol; 2005; 22(2):139-43. PubMed ID: 15965276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blood serum proteins as biomarkers for prediction of survival, locoregional control and distant metastasis rate in radiotherapy and radio-chemotherapy for non-small cell lung cancer.
    Suwinski R; Giglok M; Galwas-Kliber K; Idasiak A; Jochymek B; Deja R; Maslyk B; Mrochem-Kwarciak J; Butkiewicz D
    BMC Cancer; 2019 May; 19(1):427. PubMed ID: 31068179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated serum C-reactive protein, carcinoembryonic antigen and N2 disease are poor prognostic indicators in non-small cell lung cancer.
    Ni XF; Wu P; Wu CP; Ji M; Wu J; Gu XF; Jiang ZX
    Asia Pac J Clin Oncol; 2015 Dec; 11(4):e22-30. PubMed ID: 24889374
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CYFRA 21-1 enzyme-linked immunosorbent assay. Evaluation as a tumor marker in non-small cell lung cancer.
    Lai RS; Hsu HK; Lu JY; Ger LP; Lai NS
    Chest; 1996 Apr; 109(4):995-1000. PubMed ID: 8635383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.